OptimizeRx Corp
OPRX· Nasdaq
OPRXOptimizeRx Corp
Filed May 15, 2013 · 10-Q · 45 days after period end · 0001255294-13-000346
| Metric | Q1 2013 | Q1 2012 | Q1 2011 |
|---|---|---|---|
| Revenue | $1.10M | $329.40K | $393.84K |
| Net Income | -$224.44K | -$300.73K | -$379.93K |
| EPS Diluted | -$0.02 | — | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
OptimizeRx Corp · CIK 1448431 · Engraved from SEC EDGAR
ended Mar 31, 2013 · filed May 15, 2013 · 45 d after period end
